Pharmaceutical support in liver transplantation at a reference center in Rio Grande do Sul

• Published in: Brazilian Journal of Transplantation Vol. 20; no. 2; pp. 6 - 8
• Main Authors: Pranke, Mariana de Andrade, Zanotelli, Maria Lúcia, Fleck Jr, Alfeu, Brandão, Ajácio, Marroni, Cláudio, Cantisani, Guido
• Format: Journal Article
• Language: English
• Published: Associação Brasileira de Transplante de Órgãos 01.03.2017
• Subjects: Everolimus; Immunosuppressant; Pharmaceutical Care
• ISSN: 2764-1589; 2764-1589
• DOI: 10.53855/bjt.v20i2.80

The introduction of the everolimus as immunosuppressant in the liver transplantation has been shown to be safe and effective in the prophylaxis and preservation of the renal function. Prospective follow-up and chart analysis of liver transplant patients treated with everolimus was performed. Purpose: To highlight the importance of the pharmacist in transplantation centers. Method: Along the study, 93 patients were included, being 72 under active treatment. The successful treatment depends on the multidisciplinary follow-up, and it is extremely important the involvement of the patient, making him to become positive and an active part of the treatment. Results: The most frequent problems were: patients cutting the everolimus tablet, late SL after dose adjustment, lack of adhesion to the collection, and serum level collection out of time. Discussion: Upon the introduction of new drugs, it is required to observe possible adverse events further to ensure that the patient correctly follows the treatment. Conclusion: The presence of the pharmacist in the transplantation center allows the patient to get a reference to clarify doubts on the proper use of immunosuppressant.